Latest Breaking News On - Upcoming presentation - Page 1 : comparemela.com

Tesla Marks a Milestone: 1 Million Deliveries in Europe

Auto - Tesla, the cutting-edge electric vehicle (EV) manufacturer, has hit a significant milestone by successfully delivering its one-millionth vehicle in

Elon muskDev technologyExpansion of tesla supercharger networkStrong bondsTesla wall connectorMaster planMaking electric vehiclesTesla roadsterUpgraded modelLeap forwardUpcoming presentationTesla modelTesla store

Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517 in Individuals with PKU

Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517 in Individuals with PKU
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalUnited statesJohn throupCaryo hardingGeorge vratsanosJosh rappaportBain capital life sciencesHead of development at jnana therapeuticsJnana therapeutics incDrug administrationPotential first in class oral treatmentStudy follows positive clinical proofMechanism dataOral presentationStudy resultsInborn errors

Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517

JNT-517 is a Potential First-in-Class Oral Treatment for PKU; Phase 1b Study Follows Positive Clinical Proof of Mechanism Data in Healthy Individuals

United statesIsrael generalJosh rappaportCaryo hardingJohn throupGeorge vratsanosBain capital life sciencesDrug administrationHead of development at jnana therapeuticsPotential first in class oral treatmentStudy follows positive clinical proofMechanism dataOral presentationStudy resultsInborn errorsAnnual symposium

NovAccess Global Lead Scientist Published in High-Profile Medical Journal

NovAccess Global Lead Scientist Published in High-Profile Medical Journal .

United statesSanta cruz divisionChris wheelerDwaink irvinChristopher wheelerWorld orphan drug congressDepartment of chemistry biochemistryUniversity of californiaStemvax therapeutics incNovaccess global incOffice of orphan products developmentNews networkStemvax therapeutics inc drWorld brain mapping foundationSinai medical center department of neurosurgeryDrug administration

NovAccess Global Inc : NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements

Report Details Promise of Adaptive Cancer Immunotherapy in Treating Highly Malignant Brain TumorsRecent Achievements for Glioblastoma/Brain Tumor Treatment to be Addressed in Upcoming Presentation at World

United statesSanta cruz divisionDwaink irvinChristopher wheelerChris wheelerOur companyDrug administrationSinai medical center department of neurosurgeryWorld brain mapping foundationDarrow associatesUpcoming presentation at world orphan drug congressVaccine manufacturing laboratoryDepartment of chemistry biochemistrySecurities exchangeWorld orphan drug congressSecurities exchange commission